liraglutide: Head-to-head study reveals a diabetes risk difference The study involved a double-blind, placebo-controlled, multicenter, parallel clinical trial conducted across 14 locations in four countries including Spain, Canada, the Netherlands, and Germany
In the case of semaglutide, the drug mimics GLP-1, a hormone that triggers cell receptors in the digestive system and brain
A stratified Cox proportional hazards model was used, with treatment as a fixed effect and trial-level cardiovascular risk as the stratification factor, to estimate hazard ratios (HRs) and confidence intervals (CIs) when comparing tirzepatide to the control
By activating these pathways, tirzepatide helps the body: Release insulin when blood sugar rises after meals Reduce the amount of sugar released by the liver Slow how quickly food leaves the stomach Decrease appetite and increase feelings of fullness Together, these effects can improve blood sugar control and support weight loss, which are both important in managing type 2 diabetes
Electrolytes, B vitamins, magnesium, and fiber support are still valuable given the GI effects